Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 30 | 2020 | 53 | 10.210 |
Why?
|
Stents | 27 | 2020 | 171 | 8.020 |
Why?
|
Stroke | 40 | 2021 | 556 | 7.890 |
Why?
|
Neurosurgery | 15 | 2020 | 35 | 7.180 |
Why?
|
Thrombectomy | 27 | 2021 | 57 | 6.800 |
Why?
|
Embolization, Therapeutic | 22 | 2020 | 82 | 5.710 |
Why?
|
Cranial Sinuses | 9 | 2020 | 20 | 5.560 |
Why?
|
Brain Ischemia | 22 | 2020 | 142 | 4.920 |
Why?
|
Pseudotumor Cerebri | 7 | 2020 | 19 | 4.530 |
Why?
|
Neurosurgical Procedures | 19 | 2020 | 92 | 4.070 |
Why?
|
Aneurysm, Ruptured | 10 | 2020 | 25 | 3.630 |
Why?
|
Physicians | 7 | 2020 | 142 | 3.290 |
Why?
|
Burnout, Professional | 6 | 2020 | 43 | 3.240 |
Why?
|
Humans | 138 | 2021 | 29002 | 3.020 |
Why?
|
Internship and Residency | 10 | 2019 | 284 | 2.870 |
Why?
|
Cerebral Angiography | 14 | 2020 | 50 | 2.710 |
Why?
|
Treatment Outcome | 53 | 2021 | 3149 | 2.580 |
Why?
|
Postoperative Complications | 14 | 2020 | 676 | 2.260 |
Why?
|
Male | 82 | 2021 | 18242 | 2.190 |
Why?
|
Female | 83 | 2021 | 18466 | 2.140 |
Why?
|
Carotid Artery Diseases | 4 | 2018 | 122 | 2.100 |
Why?
|
Periodicals as Topic | 6 | 2020 | 96 | 2.040 |
Why?
|
Cerebrovascular Circulation | 5 | 2014 | 90 | 2.030 |
Why?
|
Adult | 44 | 2020 | 8644 | 1.970 |
Why?
|
Middle Aged | 62 | 2021 | 11242 | 1.960 |
Why?
|
Carotid Artery, Internal | 3 | 2018 | 29 | 1.830 |
Why?
|
Retrospective Studies | 37 | 2020 | 3074 | 1.820 |
Why?
|
Prospective Studies | 21 | 2021 | 1989 | 1.690 |
Why?
|
Venous Pressure | 3 | 2020 | 9 | 1.690 |
Why?
|
Blood Vessel Prosthesis | 4 | 2020 | 79 | 1.570 |
Why?
|
Manometry | 3 | 2019 | 23 | 1.500 |
Why?
|
Job Satisfaction | 2 | 2020 | 35 | 1.490 |
Why?
|
Carbon Dioxide | 2 | 2020 | 36 | 1.470 |
Why?
|
Health Personnel | 2 | 2020 | 108 | 1.460 |
Why?
|
Bibliometrics | 2 | 2019 | 8 | 1.410 |
Why?
|
Cerebrovascular Disorders | 3 | 2018 | 53 | 1.400 |
Why?
|
Evidence-Based Medicine | 5 | 2017 | 209 | 1.380 |
Why?
|
Aged | 46 | 2021 | 9677 | 1.280 |
Why?
|
Health Promotion | 3 | 2019 | 226 | 1.270 |
Why?
|
Coronavirus Infections | 4 | 2020 | 72 | 1.270 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 77 | 1.270 |
Why?
|
Fibrinolytic Agents | 6 | 2019 | 69 | 1.250 |
Why?
|
Iatrogenic Disease | 4 | 2015 | 14 | 1.250 |
Why?
|
Phlebography | 4 | 2020 | 26 | 1.250 |
Why?
|
Workload | 3 | 2018 | 40 | 1.230 |
Why?
|
Angiography | 5 | 2018 | 79 | 1.200 |
Why?
|
Hospitalization | 7 | 2021 | 403 | 1.180 |
Why?
|
Biomedical Research | 2 | 2017 | 164 | 1.150 |
Why?
|
Intracranial Hypertension | 2 | 2018 | 21 | 1.150 |
Why?
|
Healthcare Disparities | 3 | 2021 | 142 | 1.150 |
Why?
|
United States | 17 | 2020 | 3701 | 1.120 |
Why?
|
Thromboembolism | 3 | 2019 | 33 | 1.110 |
Why?
|
Intracranial Hemorrhages | 4 | 2015 | 30 | 1.100 |
Why?
|
Cerebral Revascularization | 6 | 2020 | 9 | 1.070 |
Why?
|
Referral and Consultation | 3 | 2018 | 111 | 1.070 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2017 | 23 | 1.050 |
Why?
|
Femoral Artery | 3 | 2020 | 44 | 1.050 |
Why?
|
Insurance Coverage | 2 | 2015 | 72 | 1.050 |
Why?
|
Decompression, Surgical | 3 | 2013 | 52 | 1.020 |
Why?
|
Constriction, Pathologic | 5 | 2018 | 37 | 1.010 |
Why?
|
Intracranial Pressure | 4 | 2019 | 17 | 1.000 |
Why?
|
Retreatment | 3 | 2020 | 42 | 0.990 |
Why?
|
Disease Management | 3 | 2019 | 126 | 0.990 |
Why?
|
Medical Errors | 2 | 2014 | 37 | 0.950 |
Why?
|
Accreditation | 2 | 2013 | 13 | 0.950 |
Why?
|
Patient Selection | 4 | 2018 | 264 | 0.930 |
Why?
|
Arterial Occlusive Diseases | 3 | 2016 | 31 | 0.890 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2012 | 20 | 0.890 |
Why?
|
Mental Health | 3 | 2019 | 101 | 0.880 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 117 | 0.870 |
Why?
|
Efficiency | 2 | 2020 | 16 | 0.860 |
Why?
|
Journal Impact Factor | 2 | 2019 | 8 | 0.850 |
Why?
|
Aged, 80 and over | 21 | 2021 | 3728 | 0.840 |
Why?
|
Anesthesia, General | 3 | 2020 | 32 | 0.830 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 162 | 0.820 |
Why?
|
Pilot Projects | 9 | 2020 | 465 | 0.810 |
Why?
|
Physician's Role | 1 | 2020 | 44 | 0.780 |
Why?
|
Central Nervous System Vascular Malformations | 3 | 2015 | 7 | 0.770 |
Why?
|
Follow-Up Studies | 12 | 2020 | 2147 | 0.770 |
Why?
|
Cerebral Arteries | 3 | 2016 | 17 | 0.760 |
Why?
|
Ventriculostomy | 2 | 2017 | 11 | 0.740 |
Why?
|
Thrombosis | 1 | 2019 | 56 | 0.730 |
Why?
|
Tissue Plasminogen Activator | 5 | 2014 | 41 | 0.730 |
Why?
|
Decompressive Craniectomy | 2 | 2016 | 5 | 0.730 |
Why?
|
Drainage | 2 | 2017 | 51 | 0.720 |
Why?
|
Superior Sagittal Sinus | 1 | 2018 | 6 | 0.720 |
Why?
|
Delivery of Health Care | 1 | 2020 | 135 | 0.710 |
Why?
|
Intracranial Hypotension | 1 | 2018 | 3 | 0.710 |
Why?
|
Transverse Sinuses | 1 | 2018 | 5 | 0.710 |
Why?
|
Young Adult | 10 | 2020 | 2409 | 0.700 |
Why?
|
Total Quality Management | 1 | 2018 | 19 | 0.690 |
Why?
|
Quality of Life | 4 | 2020 | 854 | 0.690 |
Why?
|
Aneurysm, False | 1 | 2018 | 13 | 0.690 |
Why?
|
Vascular Diseases | 1 | 2018 | 62 | 0.680 |
Why?
|
Radiography | 7 | 2014 | 348 | 0.680 |
Why?
|
Surgical Flaps | 2 | 2016 | 84 | 0.670 |
Why?
|
Middle Cerebral Artery | 4 | 2018 | 11 | 0.670 |
Why?
|
Respiration, Artificial | 1 | 2018 | 98 | 0.670 |
Why?
|
Neurology | 2 | 2020 | 39 | 0.660 |
Why?
|
Neurosciences | 1 | 2017 | 8 | 0.660 |
Why?
|
Hospitals | 2 | 2018 | 75 | 0.650 |
Why?
|
Registries | 5 | 2021 | 288 | 0.630 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2017 | 12 | 0.630 |
Why?
|
Prevalence | 5 | 2020 | 912 | 0.630 |
Why?
|
Cooperative Behavior | 1 | 2017 | 77 | 0.630 |
Why?
|
Trauma Centers | 2 | 2015 | 85 | 0.620 |
Why?
|
Occupational Health Services | 1 | 2016 | 7 | 0.610 |
Why?
|
Wakefulness | 1 | 2016 | 22 | 0.610 |
Why?
|
Professional Misconduct | 1 | 2016 | 4 | 0.610 |
Why?
|
Intracranial Arteriosclerosis | 2 | 2016 | 11 | 0.610 |
Why?
|
Equipment and Supplies | 2 | 2015 | 15 | 0.610 |
Why?
|
Cerebral Arterial Diseases | 1 | 2016 | 2 | 0.610 |
Why?
|
Device Approval | 2 | 2015 | 6 | 0.610 |
Why?
|
Skull | 1 | 2016 | 46 | 0.600 |
Why?
|
Cerebral Infarction | 3 | 2016 | 24 | 0.600 |
Why?
|
Occipital Bone | 2 | 2018 | 17 | 0.600 |
Why?
|
Tremor | 1 | 2015 | 9 | 0.590 |
Why?
|
Cervical Vertebrae | 2 | 2018 | 38 | 0.590 |
Why?
|
Checklist | 2 | 2014 | 35 | 0.590 |
Why?
|
Laminectomy | 2 | 2012 | 17 | 0.580 |
Why?
|
Equipment Failure | 1 | 2015 | 20 | 0.580 |
Why?
|
Microsurgery | 1 | 2015 | 22 | 0.580 |
Why?
|
Functional Laterality | 1 | 2015 | 60 | 0.580 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 40 | 0.570 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 84 | 0.560 |
Why?
|
Community Health Centers | 1 | 2015 | 13 | 0.560 |
Why?
|
Physical Fitness | 1 | 2016 | 116 | 0.560 |
Why?
|
Students, Medical | 1 | 2016 | 118 | 0.530 |
Why?
|
Eponyms | 1 | 2014 | 3 | 0.530 |
Why?
|
Anatomy | 1 | 2014 | 5 | 0.530 |
Why?
|
Craniotomy | 2 | 2013 | 45 | 0.520 |
Why?
|
Angioplasty | 1 | 2014 | 31 | 0.510 |
Why?
|
Coated Materials, Biocompatible | 1 | 2014 | 17 | 0.510 |
Why?
|
Neuroanatomy | 1 | 2013 | 4 | 0.510 |
Why?
|
Optic Nerve Diseases | 1 | 2013 | 12 | 0.490 |
Why?
|
Thrombolytic Therapy | 3 | 2020 | 60 | 0.490 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2013 | 1 | 0.490 |
Why?
|
Cerebral Veins | 1 | 2013 | 11 | 0.480 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2012 | 1 | 0.480 |
Why?
|
Thalamus | 1 | 2013 | 41 | 0.470 |
Why?
|
Patient Transfer | 2 | 2016 | 31 | 0.460 |
Why?
|
Clinical Competence | 2 | 2013 | 304 | 0.460 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 454 | 0.460 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 43 | 0.460 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 53 | 0.450 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 40 | 0.450 |
Why?
|
Wounds and Injuries | 1 | 2015 | 251 | 0.450 |
Why?
|
Cerebral Hemorrhage | 3 | 2019 | 60 | 0.450 |
Why?
|
Adolescent | 8 | 2020 | 3232 | 0.450 |
Why?
|
Health Care Surveys | 2 | 2017 | 184 | 0.450 |
Why?
|
Paraparesis | 1 | 2011 | 3 | 0.450 |
Why?
|
Hyperparathyroidism | 1 | 2011 | 7 | 0.450 |
Why?
|
Clinical Trials as Topic | 5 | 2015 | 308 | 0.450 |
Why?
|
Solitary Fibrous Tumors | 1 | 2011 | 1 | 0.440 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 19 | 0.440 |
Why?
|
Spinal Diseases | 1 | 2011 | 23 | 0.430 |
Why?
|
Cohort Studies | 7 | 2020 | 1694 | 0.420 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 30 | 0.420 |
Why?
|
Thoracic Vertebrae | 1 | 2011 | 42 | 0.420 |
Why?
|
Spinal Fusion | 1 | 2011 | 43 | 0.420 |
Why?
|
Sutures | 1 | 2011 | 16 | 0.420 |
Why?
|
Vascular Surgical Procedures | 1 | 2012 | 93 | 0.420 |
Why?
|
Risk Factors | 8 | 2021 | 3569 | 0.420 |
Why?
|
Exercise | 1 | 2016 | 559 | 0.420 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2011 | 68 | 0.400 |
Why?
|
Hematoma | 1 | 2010 | 23 | 0.400 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 202 | 0.400 |
Why?
|
Joint Instability | 1 | 2011 | 61 | 0.400 |
Why?
|
Abdominal Injuries | 1 | 2010 | 34 | 0.390 |
Why?
|
Recovery of Function | 4 | 2020 | 228 | 0.390 |
Why?
|
Publishing | 3 | 2020 | 57 | 0.380 |
Why?
|
Single-Blind Method | 4 | 2016 | 170 | 0.380 |
Why?
|
Penicillin G | 1 | 2009 | 3 | 0.370 |
Why?
|
Neurosyphilis | 1 | 2009 | 3 | 0.370 |
Why?
|
Reperfusion | 3 | 2020 | 16 | 0.370 |
Why?
|
Ophthalmic Artery | 3 | 2014 | 9 | 0.370 |
Why?
|
Tomography, X-Ray Computed | 6 | 2016 | 879 | 0.370 |
Why?
|
Encephalitis | 1 | 2009 | 5 | 0.370 |
Why?
|
Basilar Artery | 3 | 2018 | 8 | 0.350 |
Why?
|
Pain | 1 | 2011 | 273 | 0.340 |
Why?
|
Survival Rate | 4 | 2019 | 816 | 0.340 |
Why?
|
Data Collection | 3 | 2013 | 171 | 0.340 |
Why?
|
Vision, Ocular | 2 | 2020 | 21 | 0.330 |
Why?
|
Databases, Factual | 5 | 2018 | 336 | 0.330 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 468 | 0.320 |
Why?
|
Radial Artery | 2 | 2020 | 15 | 0.320 |
Why?
|
Multicenter Studies as Topic | 4 | 2015 | 98 | 0.320 |
Why?
|
Health Services Accessibility | 2 | 2018 | 232 | 0.310 |
Why?
|
Polyvinyls | 2 | 2015 | 7 | 0.290 |
Why?
|
Blood Pressure | 2 | 2020 | 858 | 0.270 |
Why?
|
Intracranial Thrombosis | 2 | 2016 | 8 | 0.270 |
Why?
|
Aneurysm | 2 | 2014 | 21 | 0.260 |
Why?
|
Vision Disorders | 2 | 2014 | 20 | 0.250 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 428 | 0.250 |
Why?
|
Health Care Costs | 2 | 2015 | 103 | 0.250 |
Why?
|
Hospital Mortality | 4 | 2021 | 190 | 0.250 |
Why?
|
Brain Neoplasms | 3 | 2014 | 576 | 0.240 |
Why?
|
Time Factors | 5 | 2020 | 2034 | 0.240 |
Why?
|
Puerto Rico | 2 | 2012 | 11 | 0.230 |
Why?
|
Child | 6 | 2020 | 2130 | 0.220 |
Why?
|
Retinal Artery Occlusion | 1 | 2020 | 3 | 0.210 |
Why?
|
Curriculum | 2 | 2013 | 192 | 0.210 |
Why?
|
Carotid Stenosis | 1 | 2020 | 57 | 0.200 |
Why?
|
Research | 1 | 2020 | 75 | 0.200 |
Why?
|
Accidents, Traffic | 2 | 2014 | 179 | 0.190 |
Why?
|
Universities | 1 | 2020 | 129 | 0.190 |
Why?
|
Angioplasty, Balloon | 1 | 2019 | 33 | 0.190 |
Why?
|
Risk Assessment | 3 | 2020 | 1319 | 0.190 |
Why?
|
Arteriovenous Malformations | 1 | 2019 | 8 | 0.190 |
Why?
|
Arteriovenous Fistula | 1 | 2019 | 13 | 0.180 |
Why?
|
Personal Satisfaction | 1 | 2019 | 24 | 0.180 |
Why?
|
Incidence | 3 | 2019 | 1097 | 0.180 |
Why?
|
Child, Preschool | 3 | 2020 | 1156 | 0.180 |
Why?
|
Paranasal Sinuses | 1 | 2018 | 5 | 0.180 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2018 | 7 | 0.180 |
Why?
|
Scalp | 2 | 2015 | 33 | 0.170 |
Why?
|
Mandibular Condyle | 1 | 2018 | 7 | 0.170 |
Why?
|
Blister | 1 | 2018 | 7 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 1210 | 0.170 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 85 | 0.170 |
Why?
|
Headache | 1 | 2018 | 81 | 0.170 |
Why?
|
China | 1 | 2017 | 39 | 0.170 |
Why?
|
Canada | 1 | 2017 | 49 | 0.170 |
Why?
|
International Cooperation | 1 | 2017 | 25 | 0.170 |
Why?
|
Neuronavigation | 1 | 2017 | 9 | 0.170 |
Why?
|
Spinal Fractures | 1 | 2018 | 47 | 0.160 |
Why?
|
Hydrocephalus | 1 | 2017 | 13 | 0.160 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2013 | 5 | 0.160 |
Why?
|
Physical Education and Training | 1 | 2016 | 11 | 0.160 |
Why?
|
Feasibility Studies | 1 | 2017 | 255 | 0.150 |
Why?
|
Jugular Veins | 1 | 2016 | 26 | 0.150 |
Why?
|
South Carolina | 1 | 2016 | 31 | 0.150 |
Why?
|
Linear Models | 2 | 2020 | 433 | 0.150 |
Why?
|
Suction | 1 | 2016 | 14 | 0.150 |
Why?
|
Algorithms | 3 | 2015 | 460 | 0.150 |
Why?
|
Conscious Sedation | 1 | 2016 | 23 | 0.150 |
Why?
|
Intraoperative Complications | 1 | 2016 | 50 | 0.150 |
Why?
|
Schools, Medical | 1 | 2016 | 42 | 0.150 |
Why?
|
Webcasts as Topic | 1 | 2016 | 3 | 0.150 |
Why?
|
Infant | 2 | 2011 | 936 | 0.150 |
Why?
|
Motor Skills | 1 | 2015 | 12 | 0.150 |
Why?
|
Tantalum | 1 | 2015 | 3 | 0.140 |
Why?
|
Dimethyl Sulfoxide | 1 | 2015 | 10 | 0.140 |
Why?
|
Information Dissemination | 1 | 2016 | 41 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2015 | 8 | 0.140 |
Why?
|
Aneurysm, Infected | 1 | 2015 | 4 | 0.140 |
Why?
|
Endocarditis | 1 | 2015 | 9 | 0.140 |
Why?
|
Cerebellopontine Angle | 1 | 2015 | 3 | 0.140 |
Why?
|
Rhabdomyosarcoma | 1 | 2015 | 6 | 0.140 |
Why?
|
Sleep | 1 | 2016 | 86 | 0.140 |
Why?
|
Neurilemmoma | 1 | 2015 | 14 | 0.140 |
Why?
|
Cerebellar Neoplasms | 1 | 2015 | 11 | 0.140 |
Why?
|
Severity of Illness Index | 2 | 2016 | 890 | 0.140 |
Why?
|
Vasoconstrictor Agents | 1 | 2015 | 62 | 0.140 |
Why?
|
Equipment Design | 1 | 2015 | 175 | 0.130 |
Why?
|
Pituitary Apoplexy | 1 | 2014 | 1 | 0.130 |
Why?
|
Research Design | 1 | 2016 | 281 | 0.130 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2014 | 7 | 0.130 |
Why?
|
Blindness | 1 | 2014 | 6 | 0.130 |
Why?
|
Pituitary Neoplasms | 1 | 2014 | 17 | 0.130 |
Why?
|
Malpractice | 1 | 2014 | 20 | 0.130 |
Why?
|
Health Status | 1 | 2016 | 381 | 0.130 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 33 | 0.130 |
Why?
|
Terminology as Topic | 1 | 2014 | 65 | 0.130 |
Why?
|
Comorbidity | 2 | 2013 | 557 | 0.130 |
Why?
|
Diagnostic Errors | 1 | 2014 | 41 | 0.130 |
Why?
|
Endpoint Determination | 1 | 2013 | 18 | 0.130 |
Why?
|
Models, Neurological | 1 | 2014 | 116 | 0.130 |
Why?
|
Lactic Acid | 1 | 2014 | 55 | 0.130 |
Why?
|
Work Schedule Tolerance | 1 | 2013 | 10 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2013 | 63 | 0.130 |
Why?
|
Dilatation, Pathologic | 1 | 2013 | 18 | 0.120 |
Why?
|
Polyesters | 1 | 2014 | 74 | 0.120 |
Why?
|
User-Computer Interface | 1 | 2013 | 34 | 0.120 |
Why?
|
Polymers | 1 | 2014 | 62 | 0.120 |
Why?
|
Diet | 1 | 2016 | 345 | 0.120 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 57 | 0.120 |
Why?
|
Prostheses and Implants | 1 | 2013 | 44 | 0.120 |
Why?
|
Pneumonia | 1 | 2013 | 60 | 0.120 |
Why?
|
Medicaid | 1 | 2013 | 79 | 0.120 |
Why?
|
Inpatients | 1 | 2013 | 53 | 0.120 |
Why?
|
Models, Theoretical | 1 | 2014 | 132 | 0.120 |
Why?
|
Laboratory Personnel | 1 | 2012 | 1 | 0.120 |
Why?
|
Personnel, Hospital | 1 | 2012 | 12 | 0.120 |
Why?
|
African Americans | 1 | 2021 | 1571 | 0.120 |
Why?
|
Nurses | 1 | 2012 | 14 | 0.120 |
Why?
|
Computer Simulation | 1 | 2013 | 206 | 0.120 |
Why?
|
Regional Blood Flow | 1 | 2012 | 85 | 0.110 |
Why?
|
Feedback | 1 | 2012 | 33 | 0.110 |
Why?
|
Surgery, Computer-Assisted | 1 | 2012 | 56 | 0.110 |
Why?
|
Osteitis Fibrosa Cystica | 1 | 2011 | 1 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2012 | 61 | 0.110 |
Why?
|
Parathyroidectomy | 1 | 2011 | 10 | 0.110 |
Why?
|
Treatment Failure | 1 | 2012 | 163 | 0.110 |
Why?
|
Medicare | 1 | 2013 | 178 | 0.110 |
Why?
|
Osteoclasts | 1 | 2011 | 22 | 0.110 |
Why?
|
Antiparkinson Agents | 1 | 2011 | 8 | 0.110 |
Why?
|
Quadriplegia | 1 | 2011 | 8 | 0.110 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 118 | 0.110 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 419 | 0.110 |
Why?
|
Levodopa | 1 | 2011 | 12 | 0.110 |
Why?
|
Preoperative Care | 1 | 2012 | 113 | 0.110 |
Why?
|
Spinal Cord Neoplasms | 1 | 2011 | 10 | 0.110 |
Why?
|
Neurologic Examination | 1 | 2011 | 27 | 0.110 |
Why?
|
Age Factors | 2 | 2013 | 1129 | 0.110 |
Why?
|
Syndrome | 1 | 2011 | 67 | 0.110 |
Why?
|
Deep Brain Stimulation | 1 | 2011 | 42 | 0.110 |
Why?
|
Patient Care Team | 1 | 2012 | 122 | 0.110 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 13 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2011 | 16 | 0.110 |
Why?
|
Survival Analysis | 1 | 2012 | 448 | 0.110 |
Why?
|
Parkinson Disease | 1 | 2011 | 54 | 0.100 |
Why?
|
Educational Measurement | 1 | 2011 | 108 | 0.100 |
Why?
|
Postoperative Care | 1 | 2011 | 75 | 0.100 |
Why?
|
Drug Implants | 1 | 2010 | 7 | 0.100 |
Why?
|
Hematoma, Subdural | 1 | 2010 | 12 | 0.100 |
Why?
|
Paresis | 1 | 2010 | 14 | 0.100 |
Why?
|
Reoperation | 1 | 2011 | 195 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 781 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2010 | 50 | 0.100 |
Why?
|
Disease Progression | 1 | 2012 | 596 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2014 | 376 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2012 | 730 | 0.100 |
Why?
|
Heparin | 1 | 2010 | 77 | 0.100 |
Why?
|
Cognition | 1 | 2014 | 529 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2009 | 13 | 0.090 |
Why?
|
Cholangiocarcinoma | 1 | 2009 | 17 | 0.090 |
Why?
|
Pain Measurement | 1 | 2011 | 375 | 0.090 |
Why?
|
Bile Duct Neoplasms | 1 | 2009 | 37 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 334 | 0.090 |
Why?
|
Mississippi | 1 | 2007 | 23 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 2 | 2018 | 66 | 0.080 |
Why?
|
Hypertension | 3 | 2020 | 970 | 0.080 |
Why?
|
Craniocerebral Trauma | 1 | 2007 | 56 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 283 | 0.080 |
Why?
|
Acute Disease | 2 | 2019 | 248 | 0.070 |
Why?
|
Rural Population | 1 | 2007 | 290 | 0.070 |
Why?
|
Brain | 1 | 2012 | 956 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 106 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 539 | 0.060 |
Why?
|
Internationality | 1 | 2021 | 21 | 0.050 |
Why?
|
Quarantine | 1 | 2020 | 3 | 0.050 |
Why?
|
Workflow | 1 | 2020 | 18 | 0.050 |
Why?
|
Animals | 1 | 2013 | 7387 | 0.050 |
Why?
|
Independent Living | 1 | 2020 | 60 | 0.050 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 24 | 0.050 |
Why?
|
Goals | 1 | 2020 | 31 | 0.050 |
Why?
|
Forecasting | 1 | 2020 | 134 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 93 | 0.040 |
Why?
|
Developing Countries | 1 | 2018 | 37 | 0.040 |
Why?
|
Electric Impedance | 1 | 2018 | 14 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2019 | 521 | 0.040 |
Why?
|
Triage | 1 | 2018 | 69 | 0.040 |
Why?
|
Odds Ratio | 1 | 2018 | 470 | 0.040 |
Why?
|
Boston | 1 | 2016 | 17 | 0.040 |
Why?
|
Massachusetts | 1 | 2016 | 28 | 0.040 |
Why?
|
Verapamil | 1 | 2016 | 7 | 0.040 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 74 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2018 | 667 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2016 | 56 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 1384 | 0.040 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2015 | 3 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 927 | 0.040 |
Why?
|
Drug Combinations | 1 | 2015 | 84 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 713 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 2014 | 25 | 0.030 |
Why?
|
Time | 1 | 2013 | 23 | 0.030 |
Why?
|
Health Facility Size | 1 | 2013 | 3 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2013 | 9 | 0.030 |
Why?
|
Emergencies | 1 | 2013 | 48 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 26 | 0.030 |
Why?
|
Reference Standards | 1 | 2013 | 28 | 0.030 |
Why?
|
Perfusion | 1 | 2012 | 64 | 0.030 |
Why?
|
Sex Factors | 1 | 2013 | 652 | 0.030 |
Why?
|
Aftercare | 1 | 2011 | 27 | 0.030 |
Why?
|
Recurrence | 1 | 2011 | 236 | 0.020 |
Why?
|
Risk | 1 | 2011 | 302 | 0.020 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2009 | 7 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 29 | 0.020 |
Why?
|
Endosonography | 1 | 2009 | 57 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 240 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2009 | 453 | 0.020 |
Why?
|